Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Bristol-Myers Squibb has bought an 89-acre site from MassDevelopment for its new large-scale multi-product bulk biologics manufacturing facility in Devens, Massachusetts.
Subscribe to our email newsletter
The company and MassDevelopment have also finalized agreements related to the facility’s utility infrastructure, including waste water treatment and use of electricity, water and natural gas.
The facility is projected to be operationally complete in 2009, and the company plans to submit the site for regulatory approval in 2010.
The new Devens manufacturing facility is expected to support increased production capacity for commercially available biologic compounds, such as Orencia (abatacept), and help meet future production needs of biologic compounds currently in development, including the company’s investigational treatments for solid organ transplant rejection and certain types of cancers.